Strep A—the bacterium behind strep throat and impetigo—kills hundreds of thousands of people a year, mostly young people in LMICs—yet Strep A vaccine R&D is chronically underfunded.

Strep A—the bacterium behind strep throat and impetigo—kills hundreds of thousands of people a year, mostly young people in LMICs—yet Strep A vaccine R&D is chronically underfunded.

Today, Coefficient Giving is launching the Strep A Vaccine Fund, a multi-donor initiative to accelerate vaccine development against one of the world's most neglected infectious diseases relative to its scale. Strep A kills ~639,000 people a year. There is no vaccine. I think that can change 🧵

Open Philanthropy is seeking a Program Officer to execute, expand, and refine our existing grantmaking strategies in Global Health R&D.

At Open Philanthropy, we have given away $600 million in biomedical research since 2016. That funding has supported the work of thousands of scientists across hundreds of universities, nonprofits, and...

Scientists have discovered how some children develop natural immunity to a bacterial infection, a vital breakthrough which could help develop vaccines to save up to half a million lives globally each…

Analysis by UKHSA suggests a nasal spray vaccine that off...

Rapid AI progress does not automatically mean rapid medical progress. If the point of AI progress is human flourishing, we must make other complementary investments too. Even with extremely powerful A...

Hard Drugs is a show by Saloni Dattani and Jacob Trefethen about medical innovation: how to speed it up, how to scale it up, and how to make sure lifesaving tools reach the people who need them the mo...

Hard Drugs · Episode

Hard Drugs · Episode

It is always easiest to insult your own work, so let me tell you what's wrong with the piece Rafael Dib and I just published on vaccine R&D. Our analysis is driven by a practical question: how should...

Welcome to GiveWell’s podcast sharing the latest updates on our work. Tune in for conversations with GiveWell staff members discussing current priorities of our Research team and recent developments i...

The TuriTap, a new low-tech water chlorination device that operates without electricity, entered a crucial phase of testing in January: a randomized controlled trial across 40 health care facilities i...

This link will take you to a page that’s not on LinkedIn

When models are used to inform decision-making, both their strengths and limitations must be considered. Using malaria as an example, this Perspective explains how and why models are limited and offer...

MSF report on treating AMR in people caught in challenging humanitarian settings